Abstract:In this work, pulsed laser fragmentation in liquids (LFL) in a liquid‐jet reactor is used for downsizing of drug microparticles (MP). The results show significant particle size reduction accompanied by solubility enhancement. Compared to previous works, the amount of degradation products is reduced to <1 wt.%. In addition, the underlying fragmentation mechanisms of organic MP are discussed. One challenge in the development of new drug formulations is overcoming their low solubility in relevant aqueous media. Reducing the particle size of drug powders to a few hundred nanometers is a well‐known method that leads to an increase in solubility due to an elevated total surface area. However, state‐of‐the‐art comminution techniques like cryo‐milling suffer from degradation and contamination of the drugs, particularly when sub‐micrometer diameters are aspired that require long processing times. In this work, picosecond‐pulsed laser fragmentation in liquids (LFL) of dispersed drug particles in a liquid‐jet passage reactor is used as a wear‐free comminution technique using the hydrophobic oral model drugs naproxen, prednisolone, ketoconazole, and megestrol acetate. Particle size and morphology of the drug particles are characterized using scanning electron microscopy (SEM) and changes in particle size distributions upon irradiation are quantified using an analytical centrifuge. The findings highlight the superior fragmentation efficiency of the liquid‐jet passage reactor setup, with a 100 times higher fraction of submicrometer particles (SMP) of the drugs compared to the batch control, which enhances solubility and goes along with minimal chemical degradation (<1%), determined by attenuated total reflection‐Fourier transform infrared spectroscopy (ATR‐FTIR), high‐performance liquid chromatography (HPLC), and X‐ray diffraction (XRD). Moreover, the underlying predominantly photo‐mechanically induced laser fragmentation mechanisms of organic microparticles (MP) are discussed.

Rapid and Sustainable Production of Nano and Micro Medicine Crystals Via Freeze-Dissolving Technology

Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs

Compact Crystallization, Filtration, and Drying for the Production of Active Pharmaceutical Ingredients

ESSENTIAL CRYOGLOBULINAEMIA.

Recent Progress in Antisolvent Crystallization of Pharmaceuticals with a Focus on the Membrane‐Based Technologies

Spray freeze dried uniform mannitol microspheres

Rapid Production of Nanoscale Liposomes Using a 3D-Printed Reactor-In-A-Centrifuge: Formulation, Characterisation, and Super-Resolution Imaging

Managing Cancer Pain and Symptoms of Outpatients by Rotation to Sustained-release Hydromorphone: A Prospective Clinical Trial

Continuous synthesis of drug nanocrystals by solid hollow fiber cooling crystallization

A new stilbenoid from Arundina graminifolia

Quantifying Micromolar Crystallinity in Pharmaceutical Materials Utilizing 19F Solid-State NMR

Development of Carrier-Free Nanocrystals of Poorly Water-Soluble Drugs by Exploring Metastable Zone of Nucleation

Converting nanosuspension into inhalable and redispersible nanoparticles by combined in-situ thermal gelation and spray drying

Continuous Embedded Droplet Printing in Yield‐Stress Fluids for Pharmaceutical Drug Particle Synthesis

State of the art of nanocrystals technology for delivery of poorly soluble drugs

Utilization of Charged Microdroplets for the Controlled Rapid Synthesis of Hollow Sodium Chloride Single Crystals

Ultrasonic spray freeze-drying of sucrose and mannitol-based formulations: Impact of the atomization conditions on the particle morphology and drying performance

Early clinical experience with motionless whole-body computed tomography.

DRESS: clinicopathological features of 10 cases from an University Hospital in São Paulo.

Efficient Synthesis of Submicrometer‐Sized Active Pharmaceuticals by Laser Fragmentation in a Liquid‐Jet Passage Reactor with Minimum Degradation

Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization